PATH | VRL
Menu

The Value of Demonstration Projects for New Interventions: The Case of Human Papillomavirus Vaccine Introduction in Low and Middle-Income Countries

This article, published in Human Vaccines & Immunotherapeutics, examines the value of human papillomavirus (HPV) vaccination demonstration projects, including potential drawbacks and how value for informing national scale-up might be increased. The lessons learned are relevant for countries intending to introduce HPV vaccination and more broadly to those supporting the introduction of new health interventions in low- and lower-middle-income countries.

Author: Howard N, Mounier-Jack S, Gallagher KE, et al.

Published: 2016

» Visit web page (English)

(Located at www.tandfonline.com)

Citation: Howard N, Mounier-Jack S, Gallagher KE, et al. The Value of Demonstration Projects for New Interventions: The Case of Human Papillomavirus Vaccine Introduction in Low and Middle-Income Countries. Human Vaccines & Immunotherapeutics. 2016;Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV)

Topics: Introduction and service delivery, Disease/vaccine specific information

Regions: Global